Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast (original) (raw)
Papers included in the consensus development process
Auer G, Eriksson E, Azavedo E, Caspersson T, Wallgren A: Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans. Cancer Research 44:394–396, 1984 Google Scholar
Baak JP, Chin D, van Diest PJ, Ortiz R, Matze-Cok P, Bacus SS: Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer. Laboratory Investigation 64:215–223, 1991 Google Scholar
Baildam AD, Zaloudik J, Howell A, Barnes DM, Turnbull L, Moore M, Sellwood RA: DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast. Brit J Cancer 55:553–560, 1987 Google Scholar
Beerman H, Smit VT, Kluin PM, Bonsing BA, Hermans J, Cornelisse CJ: Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer. Cytometry 12:147–154, 1991 Google Scholar
Beerman H, Bonsing BA, van de Vijver MJ, Hermans J, Kluin PM, Caspers RJ, van de Velde CJ, Cornelisse CJ: DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy. Brit J Cancer 64:139–143, 1991 Google Scholar
Beerman H, Kluin M, Hermans J, van de Velde CJH, Cornelisse CJ: Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients. Int J Cancer 45:34–39, 1990 Google Scholar
Blanco G, Holli K, Heikkinen M, Kallioniemi OP, Taskinen P: Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological grading. Brit J Cancer 62:142–146, 1990 Google Scholar
Clark GM, Mathieu MC, Owens MA, Dressler LG, Eudey L, Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff MD, et al: Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. J Clin Oncol 10:428–432, 1992 Google Scholar
Clark GM, Dressler LG, Owens MA, Pounds G, Oldaker T, McGuire WL: Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 320:627–633, 1989 Google Scholar
Cornelisse CJ, van de Velde CJ, Caspers RJ, Moolenaar AJ, Hermans J: DNA ploidy and survival in breast cancer patients. Cytometry 1987;8:225–234. Google Scholar
Coulson PB, Thornthwaite JT, Woolley TW, Sugarbaker EV, Seckinger D: Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. Cancer Res 44:4187–4196, 1984 Google Scholar
Dowle CS, Owainati A, Robins A, Burns K, Ellis IO, Elston CW, Blamey RW: Prognostic significance of the DNA content of human breast cancer. Br J Surg 74:133–136, 1987 Google Scholar
Eskelinen M, Lipponen P, Papinaho S, Aaltomaa S, Kosma V-M, Klemi P, Syrjanen K: DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer. Int J Cancer 51:555–561, 1992 Google Scholar
Fallenius AG, Auer GU, Carstensen JM: Prognostic significance of DNA measurements in 409 consecutive breast cancer patients. Cancer 62:331–341, 1988 Google Scholar
Fallenius AG, Franzen S, Auer GU: Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. Cancer 62:521–530, 1988 Google Scholar
Ferno M, Baldetorp B, Borg A, Olsson H, Sigurdsson H, Killander D: Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. Acta Oncologica 31:157–165, 1992 Google Scholar
Ferno M, Baldetorp B, Ewers SB, Idvall I, Olsson H, Sigurdsson H, Killander D: One or multiple samplings for flow cytometric DNA analyses in breast cancer — prognostic implications? Cytometry 13:241–249, 1992 Google Scholar
Fisher B, Gunduz N, Costantino J, Fisher ER, Redmond C, Mamounas EP, Siderits R: DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04. Cancer 68:1465–1475, 1991 Google Scholar
Gnant MFX, Blijham GH, Reiner A, Reiner G, Reynders M, Schutte B, van Asche C, Steger G, Jakesz R: DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised study. Eur J Cancer 28:711–716, 1992 Google Scholar
Haag D, Feichter G, Goerttler K, Kaufmann M: Influence of systematic errors on the evaluation of the S phase portions from DNA distributions of solid tumors as shown for 328 breast carcinomas. Cytometry 8:377–385, 1987 Google Scholar
Hedley DW, Rugg CA, Gelber RD: Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. Cancer Res 47: 4729–4735, 1987 Google Scholar
Isola J, Visakorpi T, Holli K, Kallioniemi OP: Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. JNCI 84:1109–1114, 1992 Google Scholar
Kallioniemi OP, Visakorpi T, Holli K, Heikkinen A, Isola J, Koivula T: Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing. Cytometry 12:413–421, 1991 Google Scholar
Kallioniemi OP, Joensuu H, Klemi P, Koivula T: Inter-laboratory comparison of DNA flow cytometric results from paraffin-embedded breast carcinomas. Breast Cancer Res Treat 17:59–61, 1990 Google Scholar
Kallioniemi OP, Blanco G, Alavaikko M, Hietanen T, Mattila J, Lauslahti K, Lehtinen M, Koivula T: Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction: a proposed classification of DNA histograms in breast cancer. Cancer 62:2183–2190, 1988 Google Scholar
Kallioniemi OP, Hietanen T, Mattila J, Lehtinen M, Lauslahti K, Koivula T: Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. Eur J Cancer Clin Oncol 23:277–282, 1987 Google Scholar
Klintenberg C, Stal O, Nordenskjold B, Wallgren A, Arvidsson S, Skoog L: Proliferative index, cytosol estrogen receptor and axillary node status as prognostic predictors in human mammary carcinoma. Breast Cancer Res Treat 7 (Suppl):99–106, 1986 Google Scholar
Kute TE, Muss HB, Cooper MR, Case LD, Buss D, Stanley V, Gregory B, Galleshaw J, Booher K: The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients. Cancer 66:1810–1816, 1990 Google Scholar
Kute TE, Gregory B, Galleshaw J, Hopkins M, Buss D, Case D: How reproducible are flow cytometry data from paraffin-embedded blocks? Cytometry 9:494–498, 1988 Google Scholar
Muss HB, Kute TE, Case LD, Smith LR, Booher C, Long R, Kammire L, Gregory B, Brockschmidt JK: The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer. Cancer 64:1894–1900, 1989 Google Scholar
Noguchi M, Taniya T, Ohta N, Koyasaki N, Miyazaki I, Mizukami Y: Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast. Breast Cancer Res Treat 19:23–31, 1991 Google Scholar
O'Reilly SM, Camplejohn RS, Barnes DM, Millis RR, Rubens RD, Richards MA: Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry [see comments]. J Clin Oncol 8:2040–2046, 1990 Google Scholar
O'Reilly SM, Camplejohn RS, Barnes DM, Millis RR, Allen D, Rubens RD, Richards MA: DNA index, S-phase fraction, histological grade and prognosis in breast cancer. Br J Cancer 61:671–674, 1990 Google Scholar
O'Reilly SM, Camplejohn RS, Millis RR, Rubens RD, Richards MA: Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancer. Eur J Cancer 26:1035–1038, 1990 Google Scholar
Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Cox C, Duque RE, Hedley DW, Mayall BH, Wheeless L: Guidelines for the implementation of clinical DNA cytometry. Breast Cancer Res Treat 28:51–53, 1993 Google Scholar
Sharma S, Mishra MC, Kapur BM, Verma K, Nath I: The prognostic significance of ploidy analysis in operable breast cancer. Cancer 68:2612–2616, 1991 Google Scholar
Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Ferno M, Killander D, Olsson H: Indicators of prognosis in node-negative breast cancer [see comments]. N Engl J Med 322:1045–1053, 1990 Google Scholar
Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Ferno M, Killander D, Olsson H, Ranstam J: Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels. Brit J Cancer 62:786–790, 1990 Google Scholar
Toikkanen S, Joensuu H, Klemi P: Nuclear DNA content as a prognostic factor in T1-2N0 breast cancer. Am J Clin Pathol 93:471–479, 1990 Google Scholar
Toikkanen S, Joensuu H, Klemi P: The prognostic significance of nuclear DNA content in invasive breast cancer — a study with long-term follow-up. Br J Cancer 60:693–700, 1989 Google Scholar
van der Linden JC, Lindeman J, Baak JP, Meijer CJ, Herman CJ: The Multivariate Prognostic Index and nuclear DNA content are independent prognostic factors in primary breast cancer patients. Cytometry 10:56–6, 1989 Google Scholar
Winchester DJ, Duda RB, August CZ, Goldschmidt RA, Wruck DM, Rademaker AW, Winchester DP, Merkel DE: The importance of DNA flow cytometry in nodenegative breast cancer. Arch Surg 125:886–889, 1990 Google Scholar
Witzig TE, Gonchoroff NJ, Therneau T, Gilbertson DT, Wold LE, Grant C, Grande J, Katzmann JA, Ahmann DL, Ingle JN: DNA content flow cytometry as a prognostic factor for node-positive breast cancer. The role of multiparameter ploidy analysis and specimen sonication. Cancer 68:1781–1788, 1991 Google Scholar
Peters WP, Shpall EJ, Jones RB, Olsen GA, Bast RC, Gockerman JP, Moore JO: High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 6: 1368–1376, 1988 Google Scholar